Fidelity® Select Pharmaceuticals Port
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
-1.9%
1 yr return
0.6%
3 Yr Avg Return
-2.3%
5 Yr Avg Return
3.8%
Net Assets
$802 M
Holdings in Top 10
73.4%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.75%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 29.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
FPHAX - Profile
Distributions
- YTD Total Return -1.9%
- 3 Yr Annualized Total Return -2.3%
- 5 Yr Annualized Total Return 4.0%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio 1.10%
- Dividend Yield 2.2%
- Dividend Distribution Frequency Semi-Annually
Fund Details
-
Legal NameFidelity® Select Pharmaceuticals Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateJun 18, 2001
-
Shares OutstandingN/A
-
Share ClassNo Load
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerKarim Suwwan de Felipe
Fund Description
FPHAX - Performance
Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.9% | -25.6% | 25.0% | 81.01% |
1 Yr | 0.6% | -27.6% | 23.5% | 35.54% |
3 Yr | -2.3%* | -19.8% | 19.7% | 61.69% |
5 Yr | 3.8%* | -13.9% | 15.3% | 34.59% |
10 Yr | 3.3%* | -6.0% | 16.7% | 65.09% |
* Annualized
Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2022 | -4.0% | -53.9% | 11.7% | 10.91% |
2021 | 0.1% | -22.3% | 18.5% | 54.60% |
2020 | 0.5% | -4.7% | 41.4% | 90.91% |
2019 | 4.9% | -10.2% | 13.1% | 50.72% |
2018 | 0.7% | -5.7% | 26.9% | 11.36% |
Total Return Ranking - Trailing
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -1.9% | -41.2% | 25.0% | 81.56% |
1 Yr | 0.6% | -28.5% | 28.3% | 38.98% |
3 Yr | -2.3%* | -19.8% | 19.7% | 62.58% |
5 Yr | 4.0%* | -13.9% | 15.3% | 41.55% |
10 Yr | 7.3%* | -6.0% | 16.7% | 54.21% |
* Annualized
Total Return Ranking - Calendar
Period | FPHAX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2022 | -4.0% | -53.9% | 11.7% | 10.91% |
2021 | 0.1% | -22.3% | 18.5% | 54.60% |
2020 | 0.5% | -4.7% | 41.4% | 90.91% |
2019 | 4.9% | -10.2% | 13.1% | 51.45% |
2018 | 0.9% | -5.7% | 26.9% | 11.36% |
NAV & Total Return History
FPHAX - Holdings
Concentration Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Assets | 802 M | 732 K | 46.2 B | 45.74% |
Number of Holdings | 74 | 3 | 507 | 49.24% |
Net Assets in Top 10 | 616 M | 2.18 K | 21.6 B | 34.01% |
Weighting of Top 10 | 73.42% | 12.3% | 100.0% | 2.03% |
Top 10 Holdings
- Eli Lilly and Co 14.33%
- AstraZeneca PLC ADR 12.36%
- Sanofi SA ADR 10.36%
- Bristol-Myers Squibb Co 9.80%
- Roche Holding AG 6.65%
- Johnson & Johnson 4.47%
- Royalty Pharma PLC Class A 4.45%
- Merck & Co Inc 4.00%
- Fidelity Revere Str Tr 3.84%
- Amgen Inc 3.81%
Asset Allocation
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Stocks | 99.07% | 0.09% | 106.13% | 45.18% |
Cash | 0.50% | -0.10% | 99.91% | 55.84% |
Other | 0.43% | -22.99% | 3.38% | 17.26% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 38.58% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 40.61% |
Bonds | 0.00% | 0.00% | 12.39% | 37.06% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 26.56% | 100.00% | 17.26% |
Utilities | 0.00% | 0.00% | 1.52% | 35.53% |
Technology | 0.00% | 0.00% | 28.70% | 40.61% |
Real Estate | 0.00% | 0.00% | 7.13% | 39.59% |
Industrials | 0.00% | 0.00% | 7.02% | 39.59% |
Financial Services | 0.00% | 0.00% | 8.43% | 51.27% |
Energy | 0.00% | 0.00% | 0.00% | 35.03% |
Communication Services | 0.00% | 0.00% | 12.28% | 39.09% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 43.65% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 38.58% |
Basic Materials | 0.00% | 0.00% | 14.83% | 53.81% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FPHAX % Rank | |
---|---|---|---|---|
US | 53.67% | 0.09% | 104.41% | 99.49% |
Non US | 45.40% | 0.00% | 45.40% | 0.51% |
FPHAX - Expenses
Operational Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.75% | 0.08% | 3.13% | 55.78% |
Management Fee | 0.52% | 0.00% | 1.25% | 26.06% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | 70.73% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FPHAX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 29.00% | 0.00% | 238.00% | 24.00% |
FPHAX - Distributions
Dividend Yield Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Dividend Yield | 2.22% | 0.00% | 2.44% | 48.02% |
Dividend Distribution Analysis
FPHAX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Semi-Annually | Annually | Monthly | Quarterly |
Net Income Ratio Analysis
FPHAX | Category Low | Category High | FPHAX % Rank | |
---|---|---|---|---|
Net Income Ratio | 1.10% | -2.54% | 1.92% | 6.90% |
Capital Gain Distribution Analysis
FPHAX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Apr 10, 2017 | $0.023 | OrdinaryDividend |
Dec 19, 2016 | $0.183 | OrdinaryDividend |
Apr 16, 2012 | $0.045 | OrdinaryDividend |
Dec 12, 2011 | $0.077 | OrdinaryDividend |
Apr 07, 2011 | $0.035 | OrdinaryDividend |
Dec 13, 2010 | $0.110 | OrdinaryDividend |
Apr 12, 2010 | $0.020 | OrdinaryDividend |
Dec 14, 2009 | $0.115 | OrdinaryDividend |
Apr 20, 2009 | $0.040 | OrdinaryDividend |
Dec 15, 2008 | $0.110 | OrdinaryDividend |
Apr 14, 2008 | $0.020 | OrdinaryDividend |
Dec 17, 2007 | $0.070 | OrdinaryDividend |
Apr 16, 2007 | $0.040 | OrdinaryDividend |
Dec 18, 2006 | $0.030 | OrdinaryDividend |
Apr 10, 2006 | $0.010 | OrdinaryDividend |
Dec 19, 2005 | $0.010 | OrdinaryDividend |
Apr 11, 2005 | $0.005 | OrdinaryDividend |
FPHAX - Fund Manager Analysis
Managers
Karim Suwwan de Felipe
Start Date
Tenure
Tenure Rank
Jul 01, 2017
4.92
4.9%
Karim Suwwan de Felipe is portfolio manager of Pharmaceuticals Portfolio, which he has managed since July 2017. Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.17 | 2.12 |